FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2802254888> ?p ?o ?g. }

• W2802254888 endingPage "66" @default.
• W2802254888 startingPage "65" @default.
• W2802254888 abstract "A 48-year-old Algerian man with azathioprine-treated ulcerative colitis developed lymphocytopenia (450 cells/mm3) prompting a switch to adalimumab. An interferon-gamma release assay (IGRA) was negative. One month later, he developed dysphagia and dysphonia, progressing to febrile laryngeal dyspnoea despite a 2-week course of amoxicillin–clavulanate and corticosteroids. Endoscopy revealed an extensive laryngeal infiltration with adherent deposits (Figure 1A). A computed tomography (CT) scan showed laryngeal circumferential oedema and a left ventricle abscess (Figure 1B), and left lower pulmonary lobe condensation with ground-glass infiltrates (Figure 1C). Levofloxacin–azithromycin combination therapy was initiated because of a positive Legionella pneumophila PCR on bronchoalveolar fluid. Laryngeal biopsy revealed neutrophilic and non-necrotic granulomatous infiltrates. Two weeks later, culture of bronchoalveolar fluid yielded multi-susceptible Mycobacterium tuberculosis. Standard anti-tuberculous multi-therapy was initiated. Of note, the lymphocytopenia had resolved (1240 cells/mm3) and the IGRA turned positive. The onset of a rash resulted in a treatment adjustment with isoniazid, pyrazinamide, and levofloxacin for a total of 9 months, and the patient’s clinical condition and CT scan results normalized. As most tuberculosis cases under anti-tumour necrosis factor alpha (TNF-α) therapy occur after 90 days of treatment (Wallis et al., 2005Wallis R.S. Broder M. Wong J. Lee A. Hog L. Reactivation of latent granulomatous infections by infliximab.Clin Infect Dis. 2005; 41: S194-S198Crossref PubMed Scopus (155) Google Scholar), this case is a reminder of the risk of rapid reactivation of latent tuberculosis, especially with monoclonal antibody preparations (Horsburgh and Rubin, 2011Horsburgh Jr., C.R. Rubin E.J. Clinical practice: latent tuberculosis infection in the United States.N Engl J Med. 2011; 397: 1441-1448Crossref Scopus (235) Google Scholar, Ledingham et al., 2005Ledingham J. Wilkinson C. Deighton C. British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti–TNF-α treatments.Rheumatology (Oxford). 2005; 44: 1205-1206Crossref PubMed Scopus (69) Google Scholar). Given the severity of tuberculosis in this population and the potential for the IGRA to fail in lymphocytopenic patients (Keane et al., 2001Keane J. Gershon S. Wise R.P. Mirabile-Levens E. Kasznica J. Schwieterman W.D. et al.Tuberculosis associated with infliximab, a tumor necrosis factor alpha neutralizing agent.N Engl J Med. 2001; 345: 1098-1104Crossref PubMed Scopus (3269) Google Scholar, Sester et al., 2014Sester M. van Leth F. Bruchfeld J. Bumbacea D. Cirillo D.M. Dilektasli A.G. et al.Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.Am J Respir Crit Care Med. 2014; 190: 1168-1176Crossref PubMed Scopus (171) Google Scholar), epidemiological risk-based therapy of latent tuberculosis could be proposed for patients originating from high burden areas (Keane et al., 2001Keane J. Gershon S. Wise R.P. Mirabile-Levens E. Kasznica J. Schwieterman W.D. et al.Tuberculosis associated with infliximab, a tumor necrosis factor alpha neutralizing agent.N Engl J Med. 2001; 345: 1098-1104Crossref PubMed Scopus (3269) Google Scholar). The authors acknowledge the members of the Lyon TB study group: Ader F, Biron F, Boibieux A, Bouaziz A, Braun E, Catho G, Chidiac C, Chumbi-Flores W, Conrad A, Couraud S, Devouassoux G, Dumitrescu O, Ferry T, Freymond N, Gerbier-Colomban S, Gillet Y, Goutelle S, Grard S, Grima R, Hees L, Hodille E, Kiakouama-Maleka L, Lina G, Maury JM, Miailhes P, Perpoint T, Perrot E, Provoost J, Reix P, Ronaux-Baron AS, Roux S, Sénéchal A, Souquet PJ, Tronc F, Valour F, Vanhems P. Funding: None. Conflict of interest: None, for all authors." @default.
• W2802254888 created "2018-05-17" @default.
• W2802254888 creator A5002471860 @default.
• W2802254888 creator A5005016980 @default.
• W2802254888 creator A5020778242 @default.
• W2802254888 creator A5024579348 @default.
• W2802254888 creator A5032108241 @default.
• W2802254888 creator A5032287963 @default.
• W2802254888 creator A5043873680 @default.
• W2802254888 creator A5060944412 @default.
• W2802254888 creator A5064668101 @default.
• W2802254888 date "2018-06-01" @default.
• W2802254888 modified "2023-10-18" @default.
• W2802254888 title "Severe laryngeal and pulmonary tuberculosis under anti-TNF-α therapy" @default.
• W2802254888 cites W2002495855 @default.
• W2802254888 cites W2023464790 @default.
• W2802254888 cites W2038535814 @default.
• W2802254888 cites W2060702171 @default.
• W2802254888 cites W2313861510 @default.
• W2802254888 doi "https://doi.org/10.1016/j.ijid.2018.04.797" @default.
• W2802254888 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29702264" @default.
• W2802254888 hasPublicationYear "2018" @default.
• W2802254888 type Work @default.
• W2802254888 sameAs 2802254888 @default.
• W2802254888 citedByCount "2" @default.
• W2802254888 countsByYear W28022548882018 @default.
• W2802254888 countsByYear W28022548882021 @default.
• W2802254888 crossrefType "journal-article" @default.
• W2802254888 hasAuthorship W2802254888A5002471860 @default.
• W2802254888 hasAuthorship W2802254888A5005016980 @default.
• W2802254888 hasAuthorship W2802254888A5020778242 @default.
• W2802254888 hasAuthorship W2802254888A5024579348 @default.
• W2802254888 hasAuthorship W2802254888A5032108241 @default.
• W2802254888 hasAuthorship W2802254888A5032287963 @default.
• W2802254888 hasAuthorship W2802254888A5043873680 @default.
• W2802254888 hasAuthorship W2802254888A5060944412 @default.
• W2802254888 hasAuthorship W2802254888A5064668101 @default.
• W2802254888 hasBestOaLocation W28022548881 @default.
• W2802254888 hasConcept C126322002 @default.
• W2802254888 hasConcept C142724271 @default.
• W2802254888 hasConcept C17991360 @default.
• W2802254888 hasConcept C2776228421 @default.
• W2802254888 hasConcept C2776301714 @default.
• W2802254888 hasConcept C2776409635 @default.
• W2802254888 hasConcept C2776962512 @default.
• W2802254888 hasConcept C2777138892 @default.
• W2802254888 hasConcept C2777714996 @default.
• W2802254888 hasConcept C2777761686 @default.
• W2802254888 hasConcept C2777961210 @default.
• W2802254888 hasConcept C2777975735 @default.
• W2802254888 hasConcept C2777990475 @default.
• W2802254888 hasConcept C2779806340 @default.
• W2802254888 hasConcept C2780132546 @default.
• W2802254888 hasConcept C2780459521 @default.
• W2802254888 hasConcept C2780867798 @default.
• W2802254888 hasConcept C2781069245 @default.
• W2802254888 hasConcept C2781137159 @default.
• W2802254888 hasConcept C2781276175 @default.
• W2802254888 hasConcept C501593827 @default.
• W2802254888 hasConcept C71924100 @default.
• W2802254888 hasConcept C86803240 @default.
• W2802254888 hasConcept C89423630 @default.
• W2802254888 hasConcept C90924648 @default.
• W2802254888 hasConceptScore W2802254888C126322002 @default.
• W2802254888 hasConceptScore W2802254888C142724271 @default.
• W2802254888 hasConceptScore W2802254888C17991360 @default.
• W2802254888 hasConceptScore W2802254888C2776228421 @default.
• W2802254888 hasConceptScore W2802254888C2776301714 @default.
• W2802254888 hasConceptScore W2802254888C2776409635 @default.
• W2802254888 hasConceptScore W2802254888C2776962512 @default.
• W2802254888 hasConceptScore W2802254888C2777138892 @default.
• W2802254888 hasConceptScore W2802254888C2777714996 @default.
• W2802254888 hasConceptScore W2802254888C2777761686 @default.
• W2802254888 hasConceptScore W2802254888C2777961210 @default.
• W2802254888 hasConceptScore W2802254888C2777975735 @default.
• W2802254888 hasConceptScore W2802254888C2777990475 @default.
• W2802254888 hasConceptScore W2802254888C2779806340 @default.
• W2802254888 hasConceptScore W2802254888C2780132546 @default.
• W2802254888 hasConceptScore W2802254888C2780459521 @default.
• W2802254888 hasConceptScore W2802254888C2780867798 @default.
• W2802254888 hasConceptScore W2802254888C2781069245 @default.
• W2802254888 hasConceptScore W2802254888C2781137159 @default.
• W2802254888 hasConceptScore W2802254888C2781276175 @default.
• W2802254888 hasConceptScore W2802254888C501593827 @default.
• W2802254888 hasConceptScore W2802254888C71924100 @default.
• W2802254888 hasConceptScore W2802254888C86803240 @default.
• W2802254888 hasConceptScore W2802254888C89423630 @default.
• W2802254888 hasConceptScore W2802254888C90924648 @default.
• W2802254888 hasLocation W28022548881 @default.
• W2802254888 hasLocation W28022548882 @default.
• W2802254888 hasLocation W28022548883 @default.
• W2802254888 hasLocation W28022548884 @default.
• W2802254888 hasOpenAccess W2802254888 @default.
• W2802254888 hasPrimaryLocation W28022548881 @default.
• W2802254888 hasRelatedWork W164901323 @default.
• W2802254888 hasRelatedWork W2038904221 @default.
• W2802254888 hasRelatedWork W2087148207 @default.
• W2802254888 hasRelatedWork W2113890414 @default.

• next